putrescine has been researched along with Hyperlipidemias in 1 studies
Hyperlipidemias: Conditions with excess LIPIDS in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Modification of the core regiochemistry and stereochemistry significantly affected the potency, metabolic stability, and oral bioavailability of the inhibitors, as did the variation of a pendent arylmethyl P3 group." | 1.35 | 2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects. ( Chen, HJ; Colletti, L; Degoey, DA; Dekhtyar, T; Flentge, CA; Flosi, WJ; Grampovnik, DJ; Kati, WM; Kempf, DJ; Klein, LL; Mamo, M; Marsh, KC; Mo, H; Molla, A; Morfitt, DC; Nguyen, B; Randolph, JT; Schmidt, JM; Stoll, V; Swanson, SJ; Yeung, CM, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Degoey, DA | 1 |
| Grampovnik, DJ | 1 |
| Flentge, CA | 1 |
| Flosi, WJ | 1 |
| Chen, HJ | 1 |
| Yeung, CM | 1 |
| Randolph, JT | 1 |
| Klein, LL | 1 |
| Dekhtyar, T | 1 |
| Colletti, L | 1 |
| Marsh, KC | 1 |
| Stoll, V | 1 |
| Mamo, M | 1 |
| Morfitt, DC | 1 |
| Nguyen, B | 1 |
| Schmidt, JM | 1 |
| Swanson, SJ | 1 |
| Mo, H | 1 |
| Kati, WM | 1 |
| Molla, A | 1 |
| Kempf, DJ | 1 |
1 other study available for putrescine and Hyperlipidemias
| Article | Year |
|---|---|
2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects.
Topics: Animals; Binding Sites; Biological Availability; Caco-2 Cells; Carbamates; Cell Membrane Permeabilit | 2009 |